<http://schema.org/headline>
"Biocon announces that it has entered into an option agreement with Bristol- Myers Squibb for Biocon's IN-105, an oral insulin drug candidate"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fiercebiotech.com/press-releases/press-release-biocon>